ISAR Bioscience at the EIC Summit 2025
Great recognition: Martha Sommer, team leader at ISAR Bioscience, has been invited to present the UniSens project at the Summit of the European Innovation Council on April 2, 2025.
Maria-Elena Torres-Padilla honoured with Leibniz Prize
ISAR Bioscience congratulates Maria-Elena Torres-Padilla, Member of the Board of the Foundation, on winning the Leibniz Prize 2025.
New member of the foundation’s board of directors
The foundation's board of trustees has appointed Dr. Barbara Krebs-Pohl to succeed Prof. Waldmann on the foundation's board of directors.
New member of the supervisory board
The foundation's board of trustees has appointed Angelika Leppert as a new member of the Supervisory Board.
New therapies for autoimmune diseases
SAR Bioscience convinced a renowned funding agency with the GO-Immun project.
Regulatory authority gives green light for further development of an Alzheimer’s antibody
The Bavarian research company ISAR Bioscience is well on the way to a new Alzheimer's therapy.
ISAR Bioscience receives manufacturing authorisation and GMP Certificate
ISAR Bioscience has been granted a manufacturing authorisation in accordance with the German Medicines Act (§13 AMG) and a GMP (Good Manufacturing Practice) certification for its facility in [...]
Federal Ministry of Education and Research funds innovative ISAR Bioscience research project on Alzheimer’s dementia
In the cooperation project with the University of Munich, cell culture models will be created for the development of novel drug therapies.
European Innovation Council selects ISAR Bioscience project for breakthrough technology in receptor research
The European Innovation Council (EIC) has announced the selection of proposals from the 2023 EIC Pathfinder Open call, which funds ideas for new breakthrough technologies.
Consortium Meeting of the BASE Lipid Project
Scientists of the BASE-Lipid consortium met for two days at Evonik's Hanau site to further coordinate their joint research.
